Institutional investors purchased a net $24.4 million shares of TXMD during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 78.80% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Generic industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAROMETER CAPITAL MANAGEMENT, IN... Bought 53.8 Thousand shares of TherapeuticsMD Inc
J.W. BURNS & CO., INC. (NEW YORK... Bought 25.3 Thousand shares of TherapeuticsMD Inc